Market News & Trends
HealthFactors Announces Collaboration With Koronis Biomedical Technologies
HealthFactors, Inc. and Koronis Biomedical Technologies (KBT) recently announced a formal collaboration designed to improve healthcare and outcomes for people with respiratory conditions associated with…
Permira Funds to Acquire Leading CDMO Lyophilization Services of New England
Permira, the global private equity firm, recently announced that a company backed by the Permira funds has signed a definitive agreement to acquire Lyophilization Services…
Opiant Pharmaceuticals Announces Results of PET Study of Nasal Spray
Opiant Pharmaceuticals, Inc. recently announced the completion of a study evaluating two doses of a naloxone nasal spray on the occupation of brain opiate receptors…
Calithera to Receive $12-Million Milestone Payment From Incyte
Calithera Biosciences, Inc. recently announced it has achieved pharmacokinetic and pharmacodynamic goals for CB-1158 which, under its agreement with Incyte Corporation, entitles the company to…
ZIOPHARM Announces Successful End-of-Phase II Meeting With FDA
ZIOPHARM Oncology, Inc. recently announced the receipt of positive guidance from an End-of-Phase II meeting with the US FDA for its lead gene therapy product…
Apeiron Biologics Receives Green Light for Marketing Approval
Apeiron Biologics recently announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval…
Cellect Announces Successful First Cancer Patient Stem Cell Transplant
Cellect Biotechnology Ltd. recently announced that the first stem cell transplant procedure has been successfully performed using its ApoGraft technology in the company’s Phase I/II…
MilliporeSigma Introduces Mobius® MyWay Portfolio for Customized Single-Use Assemblies
MilliporeSigma, a leader in single-use technology, recently launched an industry first - the Mobius® MyWay portfolio, a program that allows more flexibility, better supply predictability,…
Aptar Pharma Inaugurates Congers Site Expansion, Supports Growth in Three Directions
Aptar Pharma’s site expansion in Congers, NY, was inaugurated on March 20 by Stephan Tanda, AptarGroup’s President and CEO, Salim Haffar, President of Aptar Pharma,…
Neothetics Announces Last Subject Enrolled in Phase II Trial
Neothetics, Inc. recently announced completion of subject enrollment for its Phase II proof-of-concept trial, LIPO-202-CL-31, for the reduction of submental subcutaneous fat. “We are excited…
Second Study Validates Role in Recurrent Cardiac Events
Interleukin Genetics, Inc. recently announced the presentation of clinical data from “The Ioannina Study” at the 66th Annual Scientific Session & Expo of the American…
Cytokinetics Announces Additional Results From Phase II Trial
Cytokinetics, Inc. recently announced that additional results from COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure), a Phase II trial…
Cellaria Adds Next-Generation RNA Reprogramming & Stem Cell Services
Cellaria, LLC, a scientific innovator that develops revolutionary new cancer models for challenging tumors, recently announced the expansion of its offerings to include a suite…
Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the US prescription market for the first time with Allergan’s…
Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the US prescription market for the first time with Allergan’s…
Nemera Wins Editor's Choice Category at INTERPHEX Awards for Safelia®
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral…
Nemera Wins Editor's Choice Category at INTERPHEX Awards for Safelia®
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral…
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, is setting the industry standard for project management and…
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, is setting the industry standard for project management and…
Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells
Cell Design Labs, Inc. recently announced the issuance of U.S. Patent No. 9,587,020, titled Chimeric Antigen Receptor and Methods of Use Thereof. This patent, issued…
